111 – 120 of 342
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease
(
- Contribution to journal › Article
- 2016
-
Mark
Two phase ii randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma
(
- Contribution to journal › Article
-
Mark
Revisiting the role of the mast cell in asthma.
(
- Contribution to journal › Scientific review
-
Mark
Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance.
(
- Contribution to journal › Article
-
Mark
Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients
(
- Contribution to journal › Article
-
Mark
Bronchodilator response of advanced lung function parameters depending on COPD severity
(
- Contribution to journal › Article
-
Mark
Reslizumab for Inadequately Controlled Asthma with Elevated Blood Eosinophil Levels : a Randomized Phase 3 Study
(
- Contribution to journal › Article
-
Mark
Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies
(
- Contribution to journal › Article
-
Mark
The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
(
- Contribution to journal › Article
-
Mark
Author’s reply
(
- Contribution to journal › Letter